Delivery Order SPE2DB22D3301-SPE2DB25FX5TH
Award Date
11/19/24
Potential Completion Date
11/20/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office division. The $1,163.28 firm fixed-price delivery order is for the supply of 4,565,863,722 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.23, is for the delivery of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract...
This federal contract award, valued at $10,464.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with an ultimate completion date of October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,912,417 units of Atovaquone-Proguanil 250-100mg tablets. The contract has a firm-fixed price of $4,079.80 and a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is for the delivery of 4,565,910 units of Atovaquone-Proguanil 250-100 mg tablets over a two-year period ending on September 24, 2024. The $9,495.07 firm-fixed-price delivery order is not set aside for any specific business category. Amerisourcebergen, the prime contractor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,148.61 firm fixed price delivery order is for the supply of 4,565,164,762 units of Atovaquone-Proguanil 250-100 mg tablets. The contract has a period of performance through July 17, 2024 and is not set aside for any specific business size or socioeconomic category. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the...
This federal contract award is for the delivery of 4,565,090,979 units of Atovaquone-Proguanil 250-100 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $2,838.24 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for delivery by July 9, 2024. Amerisourcebergen holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atovaquone-Proguanil 250-100 mg tablets. The contract, valued at $25,807.93, is a firm-fixed-price delivery order with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $73,404 for the supply of Atovaquone-Proguanil 250-100 100s medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $15,579.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, a firm fixed-price delivery order, is for the supply of 4,564,957,207 units of Atovaquone-Proguanil 250-100 mg tablets. The contract has a completion date of June 21, 2024 and was awarded on June 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...